|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S1
|
$121,550
|
$3,647
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S2
|
$60,000
|
$1,800
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S3
|
$125,625
|
$3,769
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S4
|
$200,000
|
$6,000
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S5
|
$484,876
|
$14,546
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S6
|
$502,500
|
$15,075
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
4P30CA016359-37
|
$2,600,006
|
$78,000
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-08S1
|
$59,999
|
$1,200
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
4P30CA138292-08
|
$2,038,828
|
$40,777
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Virus-targeted therapeutic for EBV-Associated Malignancies
|
2R44CA153474-02A1
|
$472,008
|
$472,008
|
PERRINE, SUSAN
|
PHOENICIA BIOSCIENCES, INC.
|
|
Viral Oncology Training Grant
|
5T32CA009111-38
|
$378,220
|
$113,466
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-42S1
|
$125,000
|
$12,500
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
4P30CA014520-42
|
$4,288,496
|
$428,850
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
2P30CA014089-41
|
$6,354,897
|
$1,016,784
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-41S1
|
$59,999
|
$9,600
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-41S2
|
$37,500
|
$6,000
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Unmasking the roles of KSHV glycoproteins in virus entry and vaccine development
|
7K01CA184388-03
|
$108,808
|
$54,404
|
OGEMBO, JAVIER
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
The Role of Viral and Cellular miRNAs in B-cell Lymphomagenesis
|
4R00CA175181-03
|
$249,000
|
$249,000
|
SKALSKY, REBECCA
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
The Role of Cidofovir and Structural Analogs as Adjuvant Therapy for Glioblastoma
|
5R01CA184283-03
|
$550,450
|
$275,225
|
COBBS, CHARLES
|
SWEDISH MEDICAL CENTER, FIRST HILL
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-22S1
|
$79,482
|
$3,974
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-22S2
|
$202,481
|
$10,124
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
4P30CA060553-22
|
$4,865,180
|
$243,259
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Function of EBV LMP1 CTAR3 in Sumoylation and Oncogenesis
|
5R00CA160786-04
|
$246,208
|
$246,208
|
BENTZ, GRETCHEN
|
MERCER UNIVERSITY MACON
|
|
The effect of statins on B cell dysfunction in HIV infection
|
1R21CA200420-01A1
|
$179,988
|
$179,988
|
MARTINEZ-MAZA, OTONIEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
The 19th International Workshop on KSHV and Related Agents
|
1R13CA210906-01
|
$5,000
|
$5,000
|
FENG, PINGHUI
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Targeting Tumorigenic Pathways in Glioblastoma with Oncolytic HSV
|
4R01CA160762-05
|
$355,522
|
$355,522
|
RABKIN, SAMUEL
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Targeting KSHV malignancies and persistent infection
|
5R01CA197153-02
|
$377,438
|
$377,438
|
GAO, SHOU-JIANG
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Targeted Therapies for HIV-Associated Kaposi Sarcoma and Lymphoma
|
2R01CA163217-06
|
$342,759
|
$171,380
|
DITTMER, DIRK
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Studying the role of KSHV-encoded miRNAs
|
4R01CA119917-09
|
$301,913
|
$301,913
|
RENNE, ROLF
|
UNIVERSITY OF FLORIDA
|
|
Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies
|
ZIA BC 010885
|
$438,983
|
$395,084
|
Yarchoan, Robert
|
CCR (NCI)
|
|
Studies on drug resistance in HIV-related Kaposi's sarcoma
|
ZIA BC 011730
|
$149,425
|
$149,425
|
Gottesman, Michael
|
CCR (NCI)
|
|
Studies of HHV-8 vIL-6 Function
|
2R01CA076445-15
|
$384,750
|
$384,750
|
NICHOLAS, JOHN
|
JOHNS HOPKINS UNIVERSITY
|
|
Stanford Cancer Institute
|
2P30CA124435-09
|
$3,345,301
|
$33,453
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
SEVERABLE FUNDING FOR NCI-FREDERICK
|
261200800001E
|
$248,730,791
|
$4,886
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
Roles of Epstein-Barr virus nuclear antigens 2 and LP in B cell proliferation
|
4R01CA170023-04
|
$393,163
|
$393,163
|
KIEFF, ELLIOTT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Role of KSHV viral proteins in signaling and pathogenesis
|
4R01CA096500-14
|
$281,108
|
$281,108
|
DAMANIA, BLOSSOM
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Role of B cells in murine gammaherpesvirus 68
|
5R01CA095318-12
|
$368,305
|
$368,305
|
SPECK, SAMUEL
|
EMORY UNIVERSITY
|
|
Rhesus HHV-8 homologue in AIDS-related malignancies
|
5R01CA075922-20
|
$748,902
|
$748,902
|
WONG, SCOTT
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Regulation of KSHV infection and replication by MAPK pathways
|
4R01CA124332-10
|
$304,095
|
$304,095
|
GAO, SHOU-JIANG
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Regulation of EBV Latency by EBNA1
|
4R01CA093606-14
|
$329,956
|
$329,956
|
LIEBERMAN, PAUL
|
WISTAR INSTITUTE
|
|
Regional Oncology Research Center
|
3P30CA006973-53S1
|
$60,000
|
$600
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-53S2
|
$114,211
|
$1,142
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-53S3
|
$125,000
|
$1,250
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
4P30CA006973-53
|
$6,995,267
|
$69,953
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Reducing Cervical Cancer in Appalachia
|
3P50CA105632-10S1
|
$499,676
|
$29,981
|
PASKETT, ELECTRA
|
OHIO STATE UNIVERSITY
|
|
Receptor Mediated SPECT Imaging Of Kaposi Sarcoma With 99mTc-Tilmanocept
|
4R44CA192859-02
|
$633,492
|
$633,492
|
COPE, FREDERICK
|
NAVIDEA BIOPHARMACEUTICALS, INC.
|
|
Reactivation of Kaposi's Sarcoma-Associated Herpesvirus
|
4R01CA091791-14
|
$284,547
|
$284,547
|
SUN, REN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Patient Oriented Research in Viral Malignancies and HIV-associated Cancers
|
ZIA BC 011700
|
$764,229
|
$534,960
|
Uldrick, Thomas
|
CCR (NCI)
|
|
Origin and Lineage of Differentiation of Kaposi's Sarcoma
|
5R21CA192744-02
|
$123,323
|
$123,323
|
SCHNEIDER, JOHANN
|
STELLENBOSCH UNIVERSITY TYGERBERG CAMPUS
|
|
Optimizing Screening for HPV-related Cancers among People Living with HIV
|
1F31CA210660-01
|
$43,576
|
$43,576
|
ROBBINS, HILARY
|
JOHNS HOPKINS UNIVERSITY
|
Total relevant funding to Herpes - Other for this search: $47,283,259
|